- Home
- SNY vs RELX Comparison
SNY vs RELX Comparison
Compare SNY & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RELX
- Stock Information
- Founded
- SNY 1994
- RELX 1903
- Country
- SNY France
- RELX United Kingdom
- Employees
- SNY N/A
- RELX N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RELX Business Services
- Sector
- SNY Health Care
- RELX Consumer Discretionary
- Exchange
- SNY Nasdaq
- RELX Nasdaq
- Market Cap
- SNY 116.5B
- RELX 97.3B
- IPO Year
- SNY N/A
- RELX N/A
- Fundamental
- Price
- SNY $48.70
- RELX $53.19
- Analyst Decision
- SNY Buy
- RELX Strong Buy
- Analyst Count
- SNY 2
- RELX 2
- Target Price
- SNY $62.50
- RELX N/A
- AVG Volume (30 Days)
- SNY 2.1M
- RELX 877.2K
- Earning Date
- SNY 07-24-2025
- RELX 07-24-2025
- Dividend Yield
- SNY 3.31%
- RELX 1.13%
- EPS Growth
- SNY 39.56
- RELX 10.15
- EPS
- SNY 5.45
- RELX 1.29
- Revenue
- SNY $48,817,552,946.00
- RELX $11,810,658,884.00
- Revenue This Year
- SNY $3.39
- RELX $9.12
- Revenue Next Year
- SNY $7.05
- RELX $7.22
- P/E Ratio
- SNY $17.56
- RELX $40.23
- Revenue Growth
- SNY N/A
- RELX 2.98
- 52 Week Low
- SNY $45.80
- RELX $43.45
- 52 Week High
- SNY $60.12
- RELX $56.33
- Technical
- Relative Strength Index (RSI)
- SNY 43.32
- RELX 48.62
- Support Level
- SNY $47.64
- RELX $52.11
- Resistance Level
- SNY $49.37
- RELX $54.37
- Average True Range (ATR)
- SNY 0.68
- RELX 0.53
- MACD
- SNY 0.14
- RELX 0.02
- Stochastic Oscillator
- SNY 30.56
- RELX 48.02
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.